ARTICLE | Company News
Neurotune, ALS Therapy Development Institute (ALS TDI) deal
May 21, 2012 7:00 AM UTC
ALS TDI said it will evaluate the efficacy of Neurotune's TDI-165 in a preclinical model of amyotrophic lateral sclerosis (ALS). TDI-165 is a biologic targeted at stabilizing the neuromuscular juncti...